Crossroads: The role of biomarkers in the management of lumps in the breast

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainA new research perspective was published inOncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in

Updated on: January 04,2024

Crossroads: The role of biomarkers in the management of lumps in the breast

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainA new research perspective was published inOncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in

Updated on:January 04,2024

GI symptoms persist in older female colorectal cancer survivors, study finds

by Emily Caldwell,The Ohio State UniversityGI symptoms in CRC survivors (Prevalence, and severity). A. Prevalence of GI symptoms with mild (blue bar) and with moderate-to-severe symptoms (red ba

Updated on: January 23,2024

GI symptoms persist in older female colorectal cancer survivors, study finds

by Emily Caldwell,The Ohio State UniversityGI symptoms in CRC survivors (Prevalence, and severity). A. Prevalence of GI symptoms with mild (blue bar) and with moderate-to-severe symptoms (red ba

Updated on:January 23,2024

Serendipity reveals new method to fight cancer with T cells

by Laura Red Eagle,University of Wisconsin-MadisonGraphical abstract. Credit:Molecular Therapy - Methods & Clinical Development(2024). DOI: 10.1016/j.omtm.2024.101249A promising

Updated on: July 05,2024

Serendipity reveals new method to fight cancer with T cells

by Laura Red Eagle,University of Wisconsin-MadisonGraphical abstract. Credit:Molecular Therapy - Methods & Clinical Development(2024). DOI: 10.1016/j.omtm.2024.101249A promising

Updated on:July 05,2024

Scientists glue two proteins together, driving cancer cells to self-destruct

by Rachel Tompa,Stanford University Medical CenterTurning kinase inhibitors into activators of therapeutic genes. Credit:Science(2024). DOI: 10.1126/science.adl5361Our bodies divest

Updated on: November 09,2024

Scientists glue two proteins together, driving cancer cells to self-destruct

by Rachel Tompa,Stanford University Medical CenterTurning kinase inhibitors into activators of therapeutic genes. Credit:Science(2024). DOI: 10.1126/science.adl5361Our bodies divest

Updated on:November 09,2024

Study hints at how cancer immunotherapy can be safer

by Bill Hathaway,Yale UniversityCredit: Unsplash/CC0 Public DomainCancer immunotherapy has revolutionized treatment of many forms of cancer by unleashing the immune system response against tumor

Updated on: February 03,2024

Study hints at how cancer immunotherapy can be safer

by Bill Hathaway,Yale UniversityCredit: Unsplash/CC0 Public DomainCancer immunotherapy has revolutionized treatment of many forms of cancer by unleashing the immune system response against tumor

Updated on:February 03,2024

Research finds global surge in cancers among the under 50s over past three decades

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThere's been a striking 79% increase in new cases of cancer among the under 50s around the world over the past three decades (1990–2

Updated on: January 23,2024

Research finds global surge in cancers among the under 50s over past three decades

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainThere's been a striking 79% increase in new cases of cancer among the under 50s around the world over the past three decades (1990–2

Updated on:January 23,2024

Metastatic cancers adapt their metabolism to the tissue in which they grow

by Ulrika Ernström,Chalmers University of TechnologyMetastatic tumors adapt their metabolism to the tissue in which they grow. The image shows a primary breast cancer tumour (pink) and the metas

Updated on: January 21,2024

Metastatic cancers adapt their metabolism to the tissue in which they grow

by Ulrika Ernström,Chalmers University of TechnologyMetastatic tumors adapt their metabolism to the tissue in which they grow. The image shows a primary breast cancer tumour (pink) and the metas

Updated on:January 21,2024

Researchers develop AI-driven tool for near real-time cancer surveillance

by Mark Alewine,Oak Ridge National LaboratoryCancer cell during cell division. Credit: National Institutes of HealthArtificial intelligence has delivered a major win for pathologists and researc

Updated on: March 20,2024

Researchers develop AI-driven tool for near real-time cancer surveillance

by Mark Alewine,Oak Ridge National LaboratoryCancer cell during cell division. Credit: National Institutes of HealthArtificial intelligence has delivered a major win for pathologists and researc

Updated on:March 20,2024

Colorectal cancer cells killed by assassin antibody, team finds

by University of SaskatchewanCredit: University of SaskatchewanColorectal cancer is the second leading cause of death from cancer in North America and is often diagnosed at an advanced stage, aft

Updated on: May 27,2024

Colorectal cancer cells killed by assassin antibody, team finds

by University of SaskatchewanCredit: University of SaskatchewanColorectal cancer is the second leading cause of death from cancer in North America and is often diagnosed at an advanced stage, aft

Updated on:May 27,2024

Strong family history of prostate cancer linked to better survival

byInstitute of Cancer ResearchAll-cause mortality among PrCa patients, by (A) the number of affected relatives and (B) degree of FH of the affected relatives. Deg.=degree; FH=&

Updated on: January 02,2024

Strong family history of prostate cancer linked to better survival

byInstitute of Cancer ResearchAll-cause mortality among PrCa patients, by (A) the number of affected relatives and (B) degree of FH of the affected relatives. Deg.=degree; FH=&

Updated on:January 02,2024

Research shows novel drug pairing could beat pancreatic cancer

byUniversity of California - San DiegoMouse pancreatic tumors were significantly smaller after being treated with a combination of KRAS inhibitor MRTX1133 and ERBB inhibitor Afatinib (bottom row

Updated on: January 16,2024

Research shows novel drug pairing could beat pancreatic cancer

byUniversity of California - San DiegoMouse pancreatic tumors were significantly smaller after being treated with a combination of KRAS inhibitor MRTX1133 and ERBB inhibitor Afatinib (bottom row

Updated on:January 16,2024

Some young cancer survivors face higher risk of premature heart failure

by Northwestern UniversityIncident Heart Failure Among YA Cancer Survivors (A) Comparison of history of anthracycline treatment vs none. (B) Stratified by young adult (YA) cancers commonly treate

Updated on: February 03,2024

Some young cancer survivors face higher risk of premature heart failure

by Northwestern UniversityIncident Heart Failure Among YA Cancer Survivors (A) Comparison of history of anthracycline treatment vs none. (B) Stratified by young adult (YA) cancers commonly treate

Updated on:February 03,2024